The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage synthetic process. Preliminary routes focused on protein section coupling, utilizing https://lexiergne440872.blogsmine.com/41015116/production-and-study-uses-of-retatrutide